Sirtuin Inhibitor as a Novel Cell Cycle Checkpoint and Regulator of the TP53-MDM2 Pathway in Uveal Melanoma
Zachary K. Goldsmith(University of Tennessee Health Science Center), Vanessa Morales-Tirado(University of Tennessee Health Science Center)
Cited by 1
Related Papers
Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma
|BMC Cancer|2017|276
Pioglitazone alters monocyte populations and stimulates recent thymic emigrants in the BBDZR/Wor type 2 diabetes rat model
|Diabetology & Metabolic Syndrome|2015|11